NFTRH+; This Sector is at Better Risk vs. Reward Than the Broad US Market

The Healthcare sector has the fundamental benefit of riding more smoothly through economic down cycles (this is my actual real world experience, having supplied medical device companies in a former life) and now the XLV/SPY ratio appears to be at a logical bottom and relative buy level. The message? Insofar as you wish to own US stocks have a focus on Healthcare stocks (BioPharma, Insurance/Services, Medical Device/Equipment, etc.).

The daily chart is forming a nice pattern at the SMA 200 and RSI is looking good.

The weekly chart shows that the pattern above is coming at very clear support and that the April high was a key higher high to the 2019 high.

Just an FYI for anyone interested.